Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 2
2013 2
2014 1
2015 5
2016 1
2017 6
2018 5
2019 5
2020 2
2021 1
2022 7
2023 9
2024 8
2025 5
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA.
Heger JM, Mattlener J, Schneider J, Gödel P, Sieg N, Ullrich F, Lewis R, Bucaciuc-Mracica T, Schwarz RF, Rueß D, Ruge MI, Montesinos-Rongen M, Deckert M, Blau T, Kutsch N, Balke-Want H, Weiss J, Becker K, Reinhardt HC, Hallek M, Borchmann P, von Tresckow B, Borchmann S. Heger JM, et al. Among authors: blau t. Blood. 2024 Feb 8;143(6):522-534. doi: 10.1182/blood.2023022020. Blood. 2024. PMID: 37946299 Free article.
Temporal Muscle Thickness as a Prognostic Marker in a Real-Life Cohort of Newly Diagnosed MGMT Promoter Methylated Glioblastoma: A Multicentric Imaging Analysis.
Lazaridis L, Moenninghoff C, Bumes E, Spille DC, Müther M, Schulz T, Heider S, Agkatsev S, Schmidt T, Blau T, Oster C, Stummer W, Kessler AF, Seidel C, Grauer O, Hau P, Ahmadipour Y, Sure U, Keyvani K, Herrlinger U, Kleinschnitz C, Stuschke M, Guberina N, Herrmann K, Deuschl C, Scheffler B, Kebir S, Glas M. Lazaridis L, et al. Among authors: blau t. Cancer Med. 2025 Apr;14(8):e70689. doi: 10.1002/cam4.70689. Cancer Med. 2025. PMID: 40260649 Free PMC article.
The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, 68Ga-FAPI-46 PET Data, and Survival Data.
Oster C, Kessler L, Blau T, Keyvani K, Pabst KM, Fendler WP, Fragoso Costa P, Lazaridis L, Schmidt T, Feldheim J, Pierscianek D, Schildhaus HU, Sure U, Ahmadipour Y, Kleinschnitz C, Guberina N, Stuschke M, Deuschl C, Scheffler B, Herrmann K, Kebir S, Glas M. Oster C, et al. Among authors: blau t. J Nucl Med. 2024 Aug 1;65(8):1217-1223. doi: 10.2967/jnumed.123.267151. J Nucl Med. 2024. PMID: 38960714 Free article.
KDM5B predicts temozolomide-resistant subclones in glioblastoma.
Ullrich V, Ertmer S, Baginska A, Dorsch M, Gull HH, Cima I, Berger P, Dobersalske C, Langer S, Meyer L, Dujardin P, Kebir S, Glas M, Blau T, Keyvani K, Rauschenbach L, Sure U, Roesch A, Grüner BM, Scheffler B. Ullrich V, et al. Among authors: blau t. iScience. 2023 Dec 3;27(1):108596. doi: 10.1016/j.isci.2023.108596. eCollection 2024 Jan 19. iScience. 2023. PMID: 38174322 Free PMC article.
Ocular Metastasis of Bronchial Typical Carcinoid.
Guo Y, Shao C, Blau T, Tannapfel A, Koch KR, Heindl LM. Guo Y, et al. Among authors: blau t. J Thorac Oncol. 2018 Sep;13(9):1422-1423. doi: 10.1016/j.jtho.2018.04.001. Epub 2018 Apr 7. J Thorac Oncol. 2018. PMID: 29635021 Free article. No abstract available.
Integrated Single-Nucleus and Spatial Transcriptomics Elucidate Heterogeneity and Hypoxia-Driven Organization of Supratentorial Ependymoma.
Schüftan E, Lu IN, de Faria FW, Inserte C, Rössig C, Bothe J, Bagosi A, Tippelt S, Blau T, Monoranu C, Altendorf L, Spille DC, Bruns AK, Brentrup A, Stummer W, Gorodezki D, Ebinger M, Schittenhelm J, Thomas C, Albert TK, Schüller U, Kerl K. Schüftan E, et al. Among authors: blau t. Cancer Res. 2026 Jan 16;86(2):540-555. doi: 10.1158/0008-5472.CAN-25-2694. Cancer Res. 2026. PMID: 41150895
Distribution and prognostic significance of myelotoxicity in newly diagnosed glioblastoma in a real-life cohort: Time to treat more aggressively?
Oster C, Reineck P, Schmidt T, Grieger J, Sharma S, Feldheim J, Kizina K, Cappello G, Jekel L, Pabst KM, Ahmadipour Y, Karadachi H, Rauschenbach L, Lazaridis L, Guberina N, Pöttgen C, Blau T, Keyvani K, Scheffler B, Herrmann K, Kleinschnitz C, Sure U, Stuschke M, Glas M, Kebir S. Oster C, et al. Among authors: blau t. Neurooncol Adv. 2025 Dec 5;7(1):vdaf218. doi: 10.1093/noajnl/vdaf218. eCollection 2025 Jan-Dec. Neurooncol Adv. 2025. PMID: 41497453 Free PMC article.
CIC/ATXN1-rearranged tumors in the central nervous system are mainly represented by sarcomas: A comprehensive clinicopathological and epigenetic series.
Tauziède-Espariat A, Ebrahimi A, Boddaert N, Pietsch T, Grajkowska W, Blau T, Koch A, Sievers P, Guillemot D, Pierron G, Uro-Coste E, Nicaise Y, Siegfried A, Gilles A, Bielle F, Mokhtari K, Cazals-Hatem D, Iakovlev G, Lhermitte B, Entz-Werle N, Csanyi M, Maurage CA, Legrand V, Boutonnat J, Godfraind C, McLeer A, Hasty L, Métais A, Aboubakr O, Blauwblomme T, Beccaria K, Dangouloff-Ros V, Varlet P; RENOCLIP‐LOC. Tauziède-Espariat A, et al. Among authors: blau t. Brain Pathol. 2025 Mar;35(2):e13303. doi: 10.1111/bpa.13303. Epub 2024 Oct 23. Brain Pathol. 2025. PMID: 39442927 Free PMC article.
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma.
Kebir S, Ullrich V, Berger P, Dobersalske C, Langer S, Rauschenbach L, Trageser D, Till A, Lorbeer FK, Wieland A, Wilhelm-Buchstab T, Ahmad A, Fröhlich H, Cima I, Prasad S, Matschke J, Jendrossek V, Remke M, Grüner BM, Roesch A, Siveke JT, Herold-Mende C, Blau T, Keyvani K, van Landeghem FKH, Pietsch T, Felsberg J, Reifenberger G, Weller M, Sure U, Brüstle O, Simon M, Glas M, Scheffler B. Kebir S, et al. Among authors: blau t. Clin Cancer Res. 2023 Jan 17;29(2):488-500. doi: 10.1158/1078-0432.CCR-22-0611. Clin Cancer Res. 2023. PMID: 36239995 Free PMC article.
Prevalence and predictors of neurological manifestations in systemic AL amyloidosis.
Thimm A, Carpinteiro A, Oubari S, Papathanasiou M, Luedike P, Kessler L, Rischpler C, Blau T, Reinhardt HC, Rassaf T, Schmidt H, Kleinschnitz C, Hagenacker T. Thimm A, et al. Among authors: blau t. J Neurol Sci. 2022 Sep 15;440:120341. doi: 10.1016/j.jns.2022.120341. Epub 2022 Jul 18. J Neurol Sci. 2022. PMID: 35872471
55 results